Researchers Detail Automated Dish System for Assisted Reproductive Technology

On November 20, 2026, researchers detailed an automated, flexible system for dish preparation and labelling in assisted reproductive technology, Nature reported.

The study notes that no animal procedures were performed as part of this work. Biocompatibility testing utilized cryopreserved one-cell B6CBAF1 mouse embryos purchased from a commercial supplier, Embryotools, which were warmed and cultured exclusively in vitro, Nature reported.

All methods followed relevant guidelines and regulations. Animal procedures required for embryo production were conducted by the supplier at the Animal Facility of the Parc Científic de Barcelona, under protocols approved by the Ethics Committee on Animal Research of the facility under approval number 10133, Nature reported.

These procedures complied with applicable institutional, national, and European legislation and regulations. This framework includes Directive 2010/63/EU, Royal Decree 53/2013, and Order 214/1997/GC, Nature reported. The Parc Científic de Barcelona Animal Facility operates as an accredited and registered breeding and user establishment for laboratory animal research, authorized by the Government of Catalonia under registration number B-9900044, Nature reported.

Adolfo Flores-Farías serves as an employee and shareholder of Conceivable Life Sciences, and is listed as a patent inventor for the company, Nature reported. Gerardo Mendizabal-Ruiz holds positions as a shareholder and patent inventor for Conceivable Life Sciences, and has received consulting fees from both Conceivable Life Sciences and IVF 2.0, Nature reported.

Alejandro Chavez-Badiola acts as an employee, shareholder, and company officer for Conceivable Life Sciences, while also holding shareholder status in IVF 2.0 and serving as a company officer for Hope IVF, Nature reported. Fátima Acosta-Gómez and Karen Aleriano are both employees and shareholders of Conceivable Life Sciences, Nature reported.

Brian Bixon, Cesar Millán, and Victor-Manuel Rico-Botero each work as employees, shareholders, and patent inventors for Conceivable Life Sciences, Nature reported. Queralt Matia-Algué is employed by Embryotools, Nature reported.

Nuno Costa-Borges holds shares, patent inventorships, and consulting roles with Conceivable Life Sciences, alongside his positions as an employee, shareholder, and company officer at Embryotools, Nature reported. Dante Sánchez-González reported no competing interests, Nature reported.

Alan Murray holds shares and company officer roles at Conceivable Life Sciences, as well as shareholdings at TMRW Life Sciences and patent inventorships linked to Conceivable Life Sciences, Nature reported. Giuseppe Silvestri works as an employee, shareholder, and patent inventor for Conceivable Life Sciences, and receives consulting fees from IVF 2.0, Nature reported.

Established by the University of Barcelona in 1997, the Parc Científic de Barcelona holds the distinction of being the first science park in Spain. Over the decades, the facility has expanded to cover an area of over 100,000 m2 and designed the country’s first bioincubator.

Mina Alikani receives consulting fees and holds shares and patent inventorships with Conceivable Life Sciences, alongside consulting fees from TMRW Life Sciences, Nature reported. Jacques Cohen serves as an employee, shareholder, and company officer at Conceivable Life Sciences, while holding shares in IVF 2.0, Althea Science, Kindbody, and Reproductive Healthcare, Nature reported.

Photo of author

Technology Desk

Technology Desk at Archyde.

CBT-I More Effective and Safer Than Sleep Meds for Chronic Insomnia